CD38 and plasma cell myeloma: Both all-trans retinoic acid (ATRA) and panobinostat have been shown to increase the expression of CD38 by myeloma cells, resulting in enhanced lysis of MM cells by daratumumab in vitro and in myeloma mouse models [12,13].